Elisabeth Linnéa Liljensten

Part of Veranex, Inc., Devicia AB is a clinical research organization (CRO) focused exclusively on medical devices. The company is based in Mölndal, Sweden. Devicia offers full-service solutions for regulatory and clinical services for medical devices, with the goal of achieving fast and predictable market access. The Swedish company provides customized lectures, training programs, and workshops within a variety of areas regarding medical devices. Elisabeth Linnéa Liljensten has been the CEO of the company since 2014. Devicia was acquired by Veranex, Inc. on October 11, 2022.

Part of Veranex, Inc., Lea Reg Ltd. is a UK-based medical device representative that assists medical device and in-vitro diagnostic companies to meet regulatory requirements. Lea Reg acts as a designated local representative or agent for non-EU based medical device and IVD companies to place their products on the EU market. The British company offers services such as EU authorized representative, EU importer, EU exporter, and EU responsible person. The company has an ISO 13485 certified quality management system and supports the entire compliance process from early pre-clinical development to post-production phase and distribution. Lea Reg's partner companies, Devicia, Limulus Bio, Clarvin, and Kickfile, provide full-service medical device compliance support. Lea Reg was acquired by Veranex, Inc. in 2022.